Responses to parliamentary questions
Question from Deputy Paula Butterly - PQ 59388-25
Reason the DPS covers only testosterone therapies designed for men and not female-specific formulations
From: Communications and public affairs
Published: November 2025
Updated: December 2025
Documents
Question from Deputy Paula Butterly - PQ 59388-25
PDF, 184KB, 2 pages
Summary
To ask the Minister for Health the reason the drugs payment scheme covers only testosterone therapies designed for men and not female-specific formulations, such as androfeme; her views on whether the HSE intends to review this policy; and if she will make a statement on the matter
This is a beta version - your feedback will help us to improve it